Market Research Logo

Central Venous Catheters - Medical Devices Pipeline Assessment, 2018

Central Venous Catheters - Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, “Central Venous Catheters - Medical Devices Pipeline Assessment, 2018 provides an overview of Central Venous Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Central Venous Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Central Venous Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Central Venous Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Central Venous Catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Central Venous Catheters Overview
3 Products under Development
3.1 Central Venous Catheters - Pipeline Products by Stage of Development
3.2 Central Venous Catheters - Pipeline Products by Segment
3.3 Central Venous Catheters - Pipeline Products by Territory
3.4 Central Venous Catheters - Pipeline Products by Regulatory Path
3.5 Central Venous Catheters - Pipeline Products by Estimated Approval Date
4 Central Venous Catheters - Pipeline Products under Development by Companies
4.1 Central Venous Catheters Companies - Pipeline Products by Stage of Development
4.2 Central Venous Catheters - Pipeline Products by Stage of Development
5 Central Venous Catheters Companies and Product Overview
5.1 Ash Access Technology Inc Company Overview
5.2 Bactiguard Holding AB Company Overview
5.3 Charite University Hospital of Berlin Company Overview
5.4 Globe Medical Tech Inc (Inactive) Company Overview
5.5 Infusense Corp Company Overview
5.6 Marvao Medical Devices Ltd Company Overview
5.7 Nipro Corp Company Overview
5.8 Pavmed Inc Company Overview
5.9 Protectus Medical Devices, Inc. Company Overview
5.10 S3V Vascular Technologies Company Overview
5.11 Sharklet Technologies Inc Company Overview
5.12 Silmag SA Company Overview
5.13 Silver Bullet Therapeutics, Inc. Company Overview
5.14 Teleflex Inc Company Overview
5.15 University of Illinois at Chicago Company Overview
5.16 University of Utah Company Overview
5.17 Vindica Therapeutics, Inc Company Overview
6 Central Venous Catheters- Recent Developments
6.1 Jun 01, 2018: BD Appoints John DeFord As Chief Technology Officer
6.2 May 22, 2018: PAVmed Announces First Quarter 2018 Financial Results
6.3 May 15, 2018: B. Braun Brings Its Commitment to The Safe Handling of Hazardous Drugs to ONS 2018
6.4 May 15, 2018: Retractable Technologies Announces Results as of March 31, 2018; Operating Loss Declined by 86.4%
6.5 May 11, 2018: BioCardia Reports First Quarter 2018 Financial Results And Business Highlights
6.6 May 11, 2018: Teleflex: Reaffirms 2018 Guidance and Provides 3-Year Financial Goals and Objectives
6.7 May 09, 2018: ICU Medical Announces First Quarter 2018 Results
6.8 May 03, 2018: BD Announces Results For 2018 Second Fiscal Quarter; Raises Fiscal 2018 Guidance
6.9 May 03, 2018: Teleflex Reports First Quarter 2018 Results
6.10 Apr 27, 2018: BD Names Three Executives to Segment Leadership Roles
6.11 Apr 20, 2018: Cook Medical Appoints Christina Anne Vice President of Distribution Channel Management
6.12 Apr 18, 2018: B. Braun Opens Five New Medical Production Facilities in Penang
6.13 Apr 02, 2018: Retractable Technologies Reports Results for the Year 2017
6.14 Mar 23, 2018: 2017 fiscal year: B. Braun increases sales and earnings, with investments of one billion euros
6.15 Mar 21, 2018: BioCardia Announces Fourth Quarter 2017 Financial Results
6.16 Mar 07, 2018: Bactiguard launches line extension to BIP CVC
6.17 Mar 01, 2018: ICU Medical Announces Fourth Quarter and Fiscal Year 2017 Results
6.18 Mar 01, 2018: Poly Medicure: Commencement of Commercial Production
6.19 Feb 22, 2018: Teleflex Reports Fourth Quarter and Full Year 2017 Results; Provides 2018 Guidance
6.20 Feb 13, 2018: Four start-ups chosen for the B. Braun Accelerator Program
6.21 Feb 12, 2018: Region Skane extends agreement with Bactiguard
6.22 Feb 06, 2018: BD Announces Results For 2018 First Fiscal Quarter; Provides Fiscal 2018 Guidance Updated For Inclusion Of Bard
6.23 Jan 18, 2018: B. Braun to Showcase Comprehensive Parenteral Nutrition Program, New Compounder and More at ASPEN
6.24 Jan 02, 2018: Teleflex Completes Previously Announced CEO Transition
6.25 Dec 15, 2017: B. Braun Launches Introcan Safety Deep Access IV Catheters
6.26 Dec 12, 2017: B. Braun establishes a subsidiary in Zambia
6.27 Nov 15, 2017: PAVmed Reports Third Quarter 2017 Financial Results
6.28 Nov 14, 2017: Retractable Technologies Announces Results as of September 30, 2017
6.29 Nov 14, 2017: Inserting And Removing Central Venous Catheters Cause Significant Discomfort In Cancer Patients And At Times Is Unnecessary
6.30 Nov 13, 2017: i360medical partners with Baptist Hospital South Florida to Launch Innovation Institute Miami
6.31 Nov 10, 2017: New clinical study shows fewer adverse events with Bactiguard’s central venous catheter compared to a standard central venous catheter
6.32 Nov 10, 2017: BioCardia Reports Third Quarter 2017 Financial Results and Business Highlights
6.33 Nov 09, 2017: ICU Medical Announces Third Quarter 2017 Results
6.34 Nov 07, 2017: Dr. Ian McNiece Appointed BioCardia Chief Scientific Officer
6.35 Nov 02, 2017: Teleflex Reports Third Quarter 2017 Results
6.36 Oct 12, 2017: CAPS to Showcase Latest 503B Quality Assurance Capabilities and Expansion Plans at Health Connect Reverse Expo - Fall Hospital Pharmacy Conference
6.37 Oct 04, 2017: Bactiguard's Central Venous Catheters Approved in Hong Kong
6.38 Aug 30, 2017: Bactiguard’s Central Venous Catheters Approved in India
6.39 Aug 23, 2017: Teleflex Awarded Group Purchasing Contract with Vizient for Non-Tunneled Central Venous Catheters
6.40 Aug 18, 2017: District Court Issues Final Judgment - Retractable Technologies v. Becton, Dickinson
6.41 Aug 14, 2017: PAVmed Reports Second Quarter 2017 Financial Results
6.42 Aug 14, 2017: Retractable Technologies Reports Results as of June 30, 2017
6.43 Aug 09, 2017: ICU Medical Announces Second Quarter 2017 Results
6.44 Aug 03, 2017: BD Announces Results For 2017 Third Fiscal Quarter
6.45 Aug 03, 2017: Teleflex Reports Second Quarter 2017 Results
6.46 Jul 31, 2017: Dr. Joachim Schulz joins the Management Board of B. Braun Melsungen
6.47 Jul 28, 2017: Indonesian Minister of Health Launches New German Pharmaceutical Factory in Karawang
6.48 Jun 29, 2017: Angel Catheter Pivotal Study Published in Journal of Vascular and Interventional Radiology
6.49 Jun 14, 2017: i360medical Announces Ray Cantwell as Chairman of the Board
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Central Venous Catheters - Pipeline Products by Stage of Development
Table 2: Central Venous Catheters - Pipeline Products by Segment
Table 3: Central Venous Catheters - Pipeline Products by Territory
Table 4: Central Venous Catheters - Pipeline Products by Regulatory Path
Table 5: Central Venous Catheters - Pipeline Products by Estimated Approval Date
Table 6: Central Venous Catheters Companies - Pipeline Products by Stage of Development
Table 7: Central Venous Catheters - Pipeline Products by Stage of Development
Table 8: Ash Access Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: BaxCath Impregnation System - Product Status
Table 10: BaxCath Impregnation System - Product Description
Table 11: Bactiguard Holding AB Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Transvascular Injection Catheter - Product Status
Table 13: Transvascular Injection Catheter - Product Description
Table 14: Charite University Hospital of Berlin Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Central Venous Permanent Catheter - Product Status
Table 16: Central Venous Permanent Catheter - Product Description
Table 17: Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Safety IV Catheter - Product Status
Table 19: Safety IV Catheter - Product Description
Table 20: Infusense Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Infusense System - Product Status
Table 22: Infusense System - Product Description
Table 23: Marvao Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 24: NexSite 8Fr Single Lumen Central Venous Catheter - Product Status
Table 25: NexSite 8Fr Single Lumen Central Venous Catheter - Product Description
Table 26: Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Biocompatible Intravenous Catheter - Product Status
Table 28: Biocompatible Intravenous Catheter - Product Description
Table 29: Pavmed Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 30: NextCath - Product Status
Table 31: NextCath - Product Description
Table 32: Protectus Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Safety IV Catheter - Product Status
Table 34: Safety IV Catheter - Product Description
Table 35: S3V Vascular Technologies Pipeline Products & Ongoing Clinical Trials Overview
Table 36: 3V AGILE - Product Status
Table 37: 3V AGILE - Product Description
Table 38: Sharklet Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Sharklet Central Venous Catheter - Product Status
Table 40: Sharklet Central Venous Catheter - Product Description
Table 41: Silmag SA Pipeline Products & Ongoing Clinical Trials Overview
Table 42: Umbilical Artery Catheter - Product Status
Table 43: Umbilical Artery Catheter - Product Description
Table 44: Umbilical Vein Catheter - Product Status
Table 45: Umbilical Vein Catheter - Product Description
Table 46: Silver Bullet Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Cathanic Venous Catheter - Product Status
Table 48: Cathanic Venous Catheter - Product Description
Table 49: Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 50: ARROW JACC Nurse Insertion CVC System - Product Status
Table 51: ARROW JACC Nurse Insertion CVC System - Product Description
Table 52: University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview
Table 53: Extendable Intravenous Catheter - Product Status
Table 54: Extendable Intravenous Catheter - Product Description
Table 55: University of Utah Pipeline Products & Ongoing Clinical Trials Overview
Table 56: WIN NIC Central Venous Catheter Introducer Kit - Product Status
Table 57: WIN NIC Central Venous Catheter Introducer Kit - Product Description
Table 58: Vindica Therapeutics, Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 59: Anti-Thrombotic And Anti-Infective Central Venous Catheter - Product Status
Table 60: Anti-Thrombotic And Anti-Infective Central Venous Catheter - Product Description
Table 61: Glossary
1.2 List of Figures
Figure 1: Central Venous Catheters - Pipeline Products by Stage of Development
Figure 2: Central Venous Catheters - Pipeline Products by Segment
Figure 3: Central Venous Catheters - Pipeline Products by Territory
Figure 4: Central Venous Catheters - Pipeline Products by Regulatory Path
Figure 5: Central Venous Catheters - Pipeline Products by Estimated Approval Date

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report